Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hendrix

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Clinical Laboratory Management Review : Official Publication of the Clinical Laboratory Management Association|December 10, 1990
Recruiting and retaining phlebotomistsB Hendrix, B Creel, H Jameson, et al.
Alzheimer'S Research & Therapy|May 24, 2023
Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA reviewSamuel P Dickson, Sean Hennessey, Jessie Nicodemus Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentCaleb W Dayley, Samuel P Dickson, Kent Hendrix, et al.
Statistics in Medicine|May 18, 2026
Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive DiseasesFlorian Stijven, Craig Mallinckrodt, Geert Molenberghs, et al.
Neurology. Clinical Practice|March 9, 2023
Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study FindingsAlette M Wessels, Ellen B Dennehy, Sherie A Dowsett, et al.
The Lancet. Neurology|November 4, 2017
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trialHilkka Soininen, Alina Solomon, Pieter Jelle Visser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 13, 2020
36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's diseaseHilkka Soininen, Alina Solomon, Pieter Jelle Visser, et al.
Frontiers in Medical Technology|July 6, 2026
Efficacy assessment in trials of complex and rare diseases: a comparison between the meta-analytic global statistical test and co-primary analysisSamuel P Dickson, Abe Durrant, Caleb W Dayley, et al.
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
The impact of recent approvals on future alzheimer's disease clinical development: Statistical considerations for combination trialsSamuel P Dickson, Craig Mallinckrodt, Aaron H Burstein, et al.
The Lancet. Neurology|May 3, 2008
Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trialGordon K Wilcock, Sandra E Black, Suzanne B Hendrix, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Clinical Laboratory Management Review : Official Publication of the Clinical Laboratory Management Association|December 10, 1990
Recruiting and retaining phlebotomistsB Hendrix, B Creel, H Jameson, et al.
Alzheimer'S Research & Therapy|May 24, 2023
Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA reviewSamuel P Dickson, Sean Hennessey, Jessie Nicodemus Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentCaleb W Dayley, Samuel P Dickson, Kent Hendrix, et al.
Statistics in Medicine|May 18, 2026
Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive DiseasesFlorian Stijven, Craig Mallinckrodt, Geert Molenberghs, et al.
Neurology. Clinical Practice|March 9, 2023
Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study FindingsAlette M Wessels, Ellen B Dennehy, Sherie A Dowsett, et al.
The Lancet. Neurology|November 4, 2017
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trialHilkka Soininen, Alina Solomon, Pieter Jelle Visser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 13, 2020
36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's diseaseHilkka Soininen, Alina Solomon, Pieter Jelle Visser, et al.
Frontiers in Medical Technology|July 6, 2026
Efficacy assessment in trials of complex and rare diseases: a comparison between the meta-analytic global statistical test and co-primary analysisSamuel P Dickson, Abe Durrant, Caleb W Dayley, et al.
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
The impact of recent approvals on future alzheimer's disease clinical development: Statistical considerations for combination trialsSamuel P Dickson, Craig Mallinckrodt, Aaron H Burstein, et al.
The Lancet. Neurology|May 3, 2008
Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trialGordon K Wilcock, Sandra E Black, Suzanne B Hendrix, et al.
Pageof 6